New Hydroxyurea Tablet Approved for Treatment of Multiple Blood Disorders

[January 16, 2025] – Recently, the National Drug Administration (NMPA) formally approved an improved hydroxyurea tablet for marketing, marking an important step in the treatment of blood disorders.

The new hydroxyurea tablet adopts a more efficient and safer formulation process and is indicated for a variety of diseases such as sickle cell anemia, multiple myeloproliferative disorders (e.g., chronic granulocytic leukemia and true erythrocytosis).

The Classic Antimetabolite: Hydroxycarbamide

Hydroxycarbamide (also known as hydroxyurea) has long been widely used in hematology and oncology. It interferes with DNA synthesis by inhibiting the enzyme nucleoside reductase, thereby slowing cell proliferation.

This mechanism gives it a unique advantage in the treatment of rapidly dividing abnormal cells such as sickle cells or cancer cells.

Hydroxyurea In Terms Of precautions

The use of Hydroxyurea in pregnant women may harm the fetus, which is why it is important to use reliable contraception when taking this drug.

Handling the drug session People who are not taking Hydroxyurea should avoid touching the drug.

Gloves should be worn when handling the tablets and any spillage should be wiped up immediately with a damp cloth and disposed of safely.

Future Prospects

The launch of the new hydroxyurea tablet not only represents the advancement of drug technology, but also demonstrates the R&D capability of Chinese pharmaceutical companies in the treatment of blood diseases.

Industry insiders generally believe that the drug is expected to become the “gold standard” for blood disease treatment and further promote better medical services for patients around the world.

Summary

As a multifunctional drug, hydroxyurea has demonstrated its value in the treatment of many diseases. Despite some side effects, most patients can benefit from it safely and effectively through rational management and monitoring.

In the future, with a deeper understanding of its mechanism of action and the exploration of new indications, the application prospect of hydroxyurea will be even broader.

• However, DengYue‘s efforts to increase the affordability of the medicine are critical to ensuring that more patients benefit from it. So please feel free to inquiry us for Hydroxycarbamide tablets.
• Information from DengYueMedicine, China Drug Import and Export Wholesaler offers this information as a guide, not a substitute for professional medical advice. Consult your doctor before any treatment.